Alnylam Pharmaceuticals Inc (ALNY)
150.13
+0.73
(+0.49%)
USD |
NASDAQ |
May 20, 16:00
150.13
0.00 (0.00%)
After-Hours: 16:49
Alnylam Pharmaceuticals Total Long Term Debt (Quarterly): 1.022B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.022B |
| December 31, 2023 | 1.021B |
| September 30, 2023 | 1.020B |
| June 30, 2023 | 1.019B |
| March 31, 2023 | 1.018B |
| December 31, 2022 | 1.017B |
| September 30, 2022 | 1.016B |
| June 30, 2022 | 677.72M |
| March 31, 2022 | 676.71M |
| December 31, 2021 | 675.70M |
| September 30, 2021 | 433.80M |
| June 30, 2021 | 433.15M |
| March 31, 2021 | 191.59M |
| December 31, 2020 | 191.28M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 30.00M |
| March 31, 2019 | 30.00M |
| December 31, 2018 | 30.00M |
| September 30, 2018 | 30.00M |
| June 30, 2018 | 30.00M |
| March 31, 2018 | 30.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 30.00M |
| September 30, 2017 | 150.00M |
| June 30, 2017 | 150.00M |
| March 31, 2017 | 150.00M |
| December 31, 2016 | 150.00M |
| September 30, 2016 | 150.00M |
| June 30, 2016 | 150.00M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
1.022B
Maximum
Mar 2024
522.10M
Average
554.75M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 1.275B |
| Johnson & Johnson | 33.63B |
| Pfizer Inc | 68.71B |
| BridgeBio Pharma Inc | 1.716B |
| ACADIA Pharmaceuticals Inc | 0.00 |